A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treating Chinese Children With Severe Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE4

Conditions

Adult Non-infectious Uveitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Tianjin Medical University Eye Hospital, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Zhiqing Li, Doctor) · drzhiqing_li@163.com · 13012232489